Hamburg, Germany (ots/PRNewswire) - Sasol Chemicals' Inorganics and Catalyst division announced the completion of its alumina capacity expansion at Sasol's Brunsbüttel site in Germany. The expansion will increase Sasol's alumina hydrate production capacity in Brunsbüttel by approximately 15,000 tons per annum, enabling the company to meet growing global demand for ...
Düsseldorf, Germany & Paris, France (ots) - ImmunoQure, a biotech company focused on the research and development of human autoantibodies as therapeutics for the treatment of common human diseases and the international pharmaceutical company Servier today announced the establishment of a Worldwide, exclusive ...
Nuremberg, Germany (ots/PRNewswire) - - Sydney knocks New York off 3rd place, while Melbourne jumps from 9th to 7th - Tokyo records greatest score gain of all 50 cities The latest Anholt-GfK City Brands IndexSM (CBISM) reveals that Paris retains its position at the top. For the fourth time since the survey began, the global public regards Paris as the highest rated out of 50 cities. Australian cities also show ...
Darmstadt, Germany and New York (ots/PRNewswire) - - Second Breakthrough Therapy Designation for avelumab in hard-to-treat cancer - Renal cell carcinoma, the most common form of kidney cancer, has a poor prognosis in advanced stage[1],[2] - Javelin Renal clinical development program is ongoing, including Phase III ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K./U.S. based media - First treatment in relapsing-remitting multiple sclerosis (RRMS) to show sustained clinical efficacy for up to 4 years with a maximum of 20 days of oral treatment over 2 years - Updated registration follows recent approval of Mavenclad in Europe and Canada Merck, a leading science and ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Expanded Fertility Technology portfolio highlights Merck's commitment to improve fertility treatment outcomes for patients - U.S. commercial availability expected in first half of 2018 Merck, a leading science and technology company, today ...
Hamburg, Germany (ots/PRNewswire) - After concluding a successful token pre-sale round, FinTech company The NAGA Group is launching their main token sale, which begins today on December 1, 2017. JOIN HERE! (https://nagaico.com/?reason=prnewswire3) NAGA (https://nagaico.com/?reason=prnewswire3) is proud to have a ...
Münster, Germany (ots/PRNewswire) - COMPO EXPERT GmbH (COMPO EXPERT), a leading manufacturer of specialty fertilizers for commercial use has appointed Hans-Christian Nehlsen as its new Chief Financial Officer (CFO). As a proven financial controller with deep finance experience, Mr. Nehlsen will be responsible for the Finance and Accounting, Human Resources, IT and ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media - Pivotal Phase III Javelin trial investigating avelumab as third-line treatment for patients with unresectable, recurrent or metastatic gastric cancer did not meet its pre-specified primary endpoint of superior overall survival ...
Markham, Ontario and Duren, Germany (ots/PRNewswire) - Acquisition Establishes Enghouse Networks Presence In Germany Enghouse Systems Limited (TSX: ENGH) announced today it has acquired XConnect GmbH, from XConnect Global Networks Ltd. Headquartered in Duren (outside of Cologne), XConnect GmbH provides carrier change processes and number portability services to telecommunication providers in Germany. Its software enables ...
Nuremberg, Germany (ots/PRNewswire) - When it comes to the factors that make up 'the good life', the top three most popular items selected by people internationally are good health, financial security and leisure time. These are followed by a happy marriage, travel for leisure, a home you own, and control over one's ...
Nuremberg, Germany (ots/PRNewswire) - - France leaps to second place for first time, while UK regains ground to remain third and Japan enters top five - USA is only country showing overall decline in 2017 - Germany major gains in Governance, People, and Culture In the wake of a substantial drop in global perception ...
Darmstadt, Germany (ots/PRNewswire) - - New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] - Insights of patients, nurses and doctors helped to evolve the product Merck, a leading science and technology company, today announced that the company received approval for a new version of GONAL-f® (follitropin alfa injection) prefilled pen from the U.S. Food and ...
Darmstadt, Germany (ots/PRNewswire) - - First multiple sclerosis (MS) therapy to achieve positive NICE recommendation in the shortest possible timeframe - Mavenclad has shown sustained clinical efficacy up to four years with a maximum of 20 days of oral treatment over two years Merck, a leading science and technology company, today announced that the National Institute ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K. based media. - Grant awarded across three research projects focused on prediction and defining characteristics of multiple sclerosis - Investment of EUR5 million in multiple sclerosis research funding as awards mark fifth year Merck, a leading science and ...
Darmstadt, Germany (ots/PRNewswire) - - Data suggests Mavenclad may significantly increase proportion of patients exhibiting no evidence of disease activity versus placebo - Analysis of 10,000 patient years of safety data provides further characterization of safety profile - Further data suggests the relative ...
Darmstadt, Germany (ots/PRNewswire) - - Multiple sclerosis diagnosis has a profound impact on life choices including education, career, family planning and relationships - Almost 90% of women say multiple sclerosis played a role in their separation or divorce following diagnosis - Policy interventions could help address significant gender-specific challenges Merck, a ...
Nuremberg, Germany (ots/PRNewswire) - Factors rated "very" or "extremely" important by consumers Nearly half of consumers report that "low sugar or sugar-free" and "free from GMO ingredients" are very or extremely important factors when deciding which food or beverage product to eat or drink. These factors top the list, just ahead of factors such as low-salt, organic, ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for US/UK based media Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and Evobrutinib at ECTRIMS 2017 - Important safety and immune cell analyses further characterize the selective immune reconstitution approach of Mavenclad - Continued innovation with Rebif includes analysis of NEDA and use of MAGNIMS ...
Münster, Germany (ots/PRNewswire) - Comprehensive cooperation in terms of technology development, localized production and commercialization COMPO EXPERT GmbH (COMPO EXPERT), a leading manufacturer of specialty fertilizers for commercial use and portfolio company of the London-headquartered global private equity ...
Nuremberg, Germany (ots/PRNewswire) - One in three now include "take a break from technology" in their health routine. Nuremberg, September 28, 2017 - When it comes to which activities people do regularly to maintain their physical health, it is no surprise that nearly two thirds of the online population across 17 ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canadian and UK-based media - First-ever treatment indicated for curatively unresectable Merkel cell carcinoma (MCC) and first anti-PD-L1 to be available in Japan - Japanese Ministry of Health, Labour and Welfare (MHLW) decision based on Javelin Merkel 200 study, the largest registrational trial for an immunotherapy in MCC - First Asian approval for ...
Darmstadt, Germany, and New York, Usa (ots/PRNewswire) - Not intended for US, Canadian and UK-based media - First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK - Builds on Bavencio's previous accelerated approvals in the US and recent approval in Switzerland - Approval is based on ...
Karlsruhe, Germany (ots) - - Cross reference: Picture is available at http://www.presseportal.de/pm/119247/3740239 - Cinemo's Unified Media Solution presented on a next generation In-Vehicle Infotainment (IVI) prototype Cinemo, a global leader in high performance and automotive grade multimedia playback, streaming, media management, connectivity and cloud access middleware, and Bosch Car Multimedia, a supplier of intelligent solutions, that help make the integration of ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K./U.S. based media - Big data platform to help accelerate innovative discovery, development and delivery of new approaches in cancer care - Enhanced analytical capabilities to better define personalized treatment options and help predict treatment outcomes - Focused on areas of high unmet need to help enhance ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK/U.S. based media - EUR1 million grant funded by Merck supports research with the potential to advance implementation of personalized treatment for solid tumors - Three winners selected from 100 scientifically diverse applicants worldwide Merck, a leading ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Data to showcase Merck KGaA, Darmstadt, Germany's strong and diverse pipeline ranging from immuno-oncology to DNA damage response - Avelumab data validate potential in hard-to-treat cancers and highlight progress of the JAVELIN clinical ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K. or U.S. based media ESMO 2017 abstract # Erbitux®: 576P, 593P, 1068P, 1579P; avelumab: 1227P, 913P, 1377TiP, 882P, 856P; M6620 (ATR inhibitor): 242PD; M2698 (dual p70S6K/Akt inhibitor): 370PD, 393P; tepotinib (c-Met kinase inhibitor): 701P - Data to showcase Merck's strong and diverse pipeline ranging from ...
Darmstadt, Germany (ots/PRNewswire) - - First oral short-course treatment for highly active relapsing multiple sclerosis (RMS)[1] now approved in Europe - MAVENCLAD® has shown sustained clinical efficacy for up to 4 years with a maximum of 20 days of oral treatment over 2 years - Marketing authorization includes the 28 countries of the European Union (EU), with first ...
Nuremberg, Germany (ots/PRNewswire) - - Garden centers should target people in their thirties and households with children under 12 years old, according to GfK Nearly a third of the online population across 17 countries does gardening or yard work either daily or weekly, according to data just published by GfK. This ...